Fundraising FoxIonovabio
Shenzhen, CN · 2 known investors
Find your way into Ionovabio
Sign up to see every warm intro you have to Ionovabio
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Ionovabio team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
A clinical-stage biotech company developing novel targeted cancer therapies and immunomodulatory drugs with a global equity strategy. The company operates a translational medicine platform and focuses on solid tumors and drug-resistant cancers.
Investors · 2
Lilly Asia Ventureslisted by Lilly Asia VenturesHong Kongvia Hongbo Lu · inferred
How we know: the VCSheet dataset · Not right? Tell us
Frequently asked questions
- What does Ionovabio do?
- A clinical-stage biotech company developing novel targeted cancer therapies and immunomodulatory drugs with a global equity strategy. The company operates a translational medicine platform and focuses on solid tumors and drug-resistant cancers.
- Who are Ionovabio's investors?
- Ionovabio's investors include LAV, Lilly Asia Ventures.
- Where is Ionovabio headquartered?
- Ionovabio is headquartered in Shenzhen, CN.